These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 9152607)
1. The in vitro interaction of dexmedetomidine with human liver microsomal cytochrome P4502D6 (CYP2D6). Rodrigues AD; Roberts EM Drug Metab Dispos; 1997 May; 25(5):651-5. PubMed ID: 9152607 [TBL] [Abstract][Full Text] [Related]
2. Mechanism-based inactivation of CYP2D6 by methylenedioxymethamphetamine. Heydari A; Yeo KR; Lennard MS; Ellis SW; Tucker GT; Rostami-Hodjegan A Drug Metab Dispos; 2004 Nov; 32(11):1213-7. PubMed ID: 15328252 [TBL] [Abstract][Full Text] [Related]
3. The effect of cimetidine on dextromethorphan O-demethylase activity of human liver microsomes and recombinant CYP2D6. Madeira M; Levine M; Chang TK; Mirfazaelian A; Bellward GD Drug Metab Dispos; 2004 Apr; 32(4):460-7. PubMed ID: 16680870 [TBL] [Abstract][Full Text] [Related]
4. Cytochrome P4502D6 catalyzes the O-demethylation of the psychoactive alkaloid ibogaine to 12-hydroxyibogamine. Obach RS; Pablo J; Mash DC Drug Metab Dispos; 1998 Aug; 26(8):764-8. PubMed ID: 9698290 [TBL] [Abstract][Full Text] [Related]
6. Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine. Palamanda JR; Casciano CN; Norton LA; Clement RP; Favreau LV; Lin C; Nomeir AA Drug Metab Dispos; 2001 Jun; 29(6):863-7. PubMed ID: 11353755 [TBL] [Abstract][Full Text] [Related]
7. Interaction of terfenadine and its primary metabolites with cytochrome P450 2D6. Jones BC; Hyland R; Ackland M; Tyman CA; Smith DA Drug Metab Dispos; 1998 Sep; 26(9):875-82. PubMed ID: 9733666 [TBL] [Abstract][Full Text] [Related]
8. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A. Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860 [TBL] [Abstract][Full Text] [Related]
9. Neuronal cytochrome P450IID1 (debrisoquine/sparteine-type): potent inhibition of activity by (-)-cocaine and nucleotide sequence identity to human hepatic P450 gene CYP2D6. Tyndale RF; Sunahara R; Inaba T; Kalow W; Gonzalez FJ; Niznik HB Mol Pharmacol; 1991 Jul; 40(1):63-8. PubMed ID: 1857341 [TBL] [Abstract][Full Text] [Related]
10. The impact of experimental design on assessing mechanism-based inactivation of CYP2D6 by MDMA (Ecstasy). Van LM; Heydari A; Yang J; Hargreaves J; Rowland-Yeo K; Lennard MS; Tucker GT; Rostami-Hodjegan A J Psychopharmacol; 2006 Nov; 20(6):834-41. PubMed ID: 16478752 [TBL] [Abstract][Full Text] [Related]
11. The potential for CYP2D6 inhibition screening using a novel scintillation proximity assay-based approach. Delaporte E; Slaughter DE; Egan MA; Gatto GJ; Santos A; Shelley J; Price E; Howells L; Dean DC; Rodrigues AD J Biomol Screen; 2001 Aug; 6(4):225-31. PubMed ID: 11689122 [TBL] [Abstract][Full Text] [Related]
12. Improved reliability of the rapid microtiter plate assay using recombinant enzyme in predicting CYP2D6 inhibition in human liver microsomes. Favreau LV; Palamanda JR; Lin CC; Nomeir AA Drug Metab Dispos; 1999 Apr; 27(4):436-9. PubMed ID: 10101136 [TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6. Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282 [TBL] [Abstract][Full Text] [Related]
14. The effect of etomidate on rabbit liver microsomal drug metabolism in vitro. Horai Y; White PF; Trevor AJ Drug Metab Dispos; 1985; 13(3):364-7. PubMed ID: 2861997 [TBL] [Abstract][Full Text] [Related]
15. Tryptamine: a possible endogenous substrate for CYP2D6. Martínez C; Agúndez JA; Gervasini G; Martín R; Benítez J Pharmacogenetics; 1997 Apr; 7(2):85-93. PubMed ID: 9170145 [TBL] [Abstract][Full Text] [Related]
16. Mechanism-based inactivation of cytochrome P450 2D6 by 1-[(2-ethyl-4-methyl-1H-imidazol-5-yl)methyl]- 4-[4-(trifluoromethyl)-2-pyridinyl]piperazine: kinetic characterization and evidence for apoprotein adduction. Hutzler JM; Steenwyk RC; Smith EB; Walker GS; Wienkers LC Chem Res Toxicol; 2004 Feb; 17(2):174-84. PubMed ID: 14967005 [TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of the cytochrome P-450 3A-mediated human liver microsomal metabolism of a novel HIV protease inhibitor by ritonavir: A positive drug-drug interaction. Kumar GN; Dykstra J; Roberts EM; Jayanti VK; Hickman D; Uchic J; Yao Y; Surber B; Thomas S; Granneman GR Drug Metab Dispos; 1999 Aug; 27(8):902-8. PubMed ID: 10421617 [TBL] [Abstract][Full Text] [Related]
18. Regioselective and stereoselective oxidation of metoprolol and bufuralol catalyzed by microsomes containing cDNA-expressed human P4502D6. Mautz DS; Nelson WL; Shen DD Drug Metab Dispos; 1995 Apr; 23(4):513-7. PubMed ID: 7600921 [TBL] [Abstract][Full Text] [Related]
19. The antipsychotic clozapine is metabolized by the polymorphic human microsomal and recombinant cytochrome P450 2D6. Fischer V; Vogels B; Maurer G; Tynes RE J Pharmacol Exp Ther; 1992 Mar; 260(3):1355-60. PubMed ID: 1545398 [TBL] [Abstract][Full Text] [Related]
20. Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6. Shin JG; Soukhova N; Flockhart DA Drug Metab Dispos; 1999 Sep; 27(9):1078-84. PubMed ID: 10460810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]